Translational Research
translational research
Prof. Max Ortiz Catalan, PhD
This position includes translational research on the treatment of pain using novel devices, as well as brain imaging studies, data analysis, and machine learning to elucidate the working mechanism of the treatments and the condition itself. You will also conduct studies to further improve and develop devices and treatments, with the ultimate goal of relieving people from their chronic and debilitating pain. Information about the department and the research Our group developed a novel treatment for phantom limb pain (PLP) using myoelectric pattern recognition (machine learning) for the decoding of motor volition, and virtual and augmented reality for real-time biofeedback. This treatment is now used worldwide. However, the mechanism underlying PLP is still unknown. This position is related to the translational research involving clinical, behavioral, and brain imaging studies for better understanding of pain due to sensorimotor impairments and it's treatment. The position is within the Center for Bionics and Pain Research (CBPR), a multidisciplinary engineering and medical collaboration between Chalmers University of Technology, Sahlgrenska University Hospital, and the Sahlgrenska Academy at the University of Gothenburg. The mission of CBPR is to develop and clinically implement technologies to eliminate disability and pain due to sensorimotor impairment. The person will be officially employed at the Department of Electrical Engineering at Chalmers, where we conduct internationally renowned research in biomedical engineering, antenna systems, signal processing, image analysis, automatic control, automation, mechatronics, and communication systems. Major responsibilities Your main responsibilites will include: - Design and implementation of clinical trials. - Design and conduct behavioral and brain imagining studies. - Literature reviews on treatments and epidemiology of pain. Contract terms Full-time temporary employment. The position is limited to a maximum of three years (two years initially with a possible extension to three years). We offer Chalmers offers a cultivating and inspiring working environment in the coastal city of Gothenburg. Read more about working at Chalmers and our benefits for employees at https://www.chalmers.se/en/about-chalmers/Working-at-Chalmers/Pages/default.aspx CBPR is located within Sahlgrenska University Hospital in Mölndal, and you can read more about our work and our team at https://cbpr.se/ Chalmers aims to actively improve our gender balance. We work broadly with equality projects, for example the GENIE Initiative on gender equality for excellence. Equality and diversity are substantial foundations in all activities at Chalmers. Application procedure The application should be marked with Ref 20220311 and written in English. The application should be sent electronically and be attached as PDF-files, as below. Maximum size for each file is 40 MB. Please note that the system does not support Zip files. CV: (Please name the document as: CV, Surname, Ref. number) including: • CV, include complete list of publications • Two references that we can contact. Personal letter: (Please name the document as: Personal letter, Family name, Ref. number) 1-3 pages where you: • Introduce yourself • Describe your previous research fields and main research results • Describe how you can contribute to CBPR's research program. Other documents: • Attested copies of completed education, grades and other certificates. <b>How to apply</b> https://www.chalmers.se/en/about-chalmers/Working-at-Chalmers/Vacancies/Pages/default.aspx?rmpage=job&rmjob=10630&rmlang=UK Use the button at the foot of the page to reach the application form. For questions, please contact: Prof. Max Ortiz Catalan, Systems and Control maxo@chalmers, +46 708461065
Dr. Ziad Nahas
Dr. Ziad Nahas (Interventional Psychiatry Lab) in the University of Minnesota Department of Psychiatry and Behavioral Sciences is seeking an outstanding candidate for a postdoctoral position to conduct and analyze the effects of neuromodulation on brain activity in mood disorders. Candidates should be passionate about advancing knowledge in the area of translational research of depressive disorders and other mental health conditions with a focus on invasive and non-invasive brain stimulation treatments. The position is available June 1, 2023, and funding is available for at least two years.
Dr. Ziad Nahas
Dr. Ziad Nahas (Interventional Psychiatry Lab) in the University of Minnesota Department of Psychiatry and Behavioral Sciences is seeking an outstanding candidate for a postdoctoral position to conduct and analyze the effects of neuromodulation on brain activity in mood disorders. Candidates should be passionate about advancing knowledge in the area of translational research of depressive disorders and other mental health conditions with a focus on invasive and non-invasive brain stimulation treatments. The position is available June 1, 2023, and funding is available for at least two years.
Joël Ouaknine
The successful candidate will work in close collaboration with academic and industrial partners, delving deep into the verification of Large Language Models (LLMs) based software programs. The focus of the position includes designing and implementing innovative verification methods to ensure the reliability and accuracy of LLM-based software programs, and actively engaging in the design and development of a system that generates high-quality data utilising LLMs. The project involves establishing methods to validate the efficacy of the prompting processes in getting accurate responses from LLMs and developing strategies to verify the overall reliability of the LLM-based software program. The postdoctoral researcher will further refine this approach, aiding in the development of a system optimised for high-quality data generation using LLMs. The successful candidate is expected to spend one or more internships in industry and liaise with industrial partners.
FENS Forum 2024
Organised by FENS in partnership with the Austrian Neuroscience Association and the Hungarian Neuroscience Society, the FENS Forum 2024 will take place on 25–29 June 2024 in Vienna, Austria:contentReference[oaicite:0]{index=0}. The FENS Forum is Europe’s largest neuroscience congress, covering all areas of neuroscience from basic to translational research:contentReference[oaicite:1]{index=1}.
Translational Research in Tuberous Sclerosis as a Model for Autism and Epilepsy
Immunosuppression for Parkinson's disease - a new therapeutic strategy?
Caroline Williams-Gray is a Principal Research Associate in the Department of Clinical Neurosciences, University of Cambridge, and an honorary consultant neurologist specializing in Parkinson’s disease and movement disorders. She leads a translational research group investigating the clinical and biological heterogeneity of PD, with the ultimate goal of developing more targeted therapies for different Parkinson’s subtypes. Her recent work has focused on the theory that the immune system plays a significant role in mediating the heterogeneity of PD and its progression. Her lab is investigating this using blood and CSF -based immune markers, PET neuroimaging and neuropathology in stratified PD cohorts; and she is leading the first randomized controlled trial repurposing a peripheral immunosuppressive drug (azathioprine) to slow the progression of PD.
Can we have jam today and jam tomorrow ?Improving outcomes for older people living with mental illness using applied and translational research
This talk will examine how approaches such as ‘big data’ and new ways of delivering clinical trials can improve current services for older people with mental illness (jam today) and identify and deliver new treatments in the future (jam tomorrow).
Identification and treatment of advanced, rupture-prone plaques to reduce cardiovascular mortality
Atherosclerosis is the underlying cause of major cardiovascular events, including heart attack and stroke. The build-up of plaque in coronary arteries can be a major risk for events, but risk is significantly higher in patients with vulnerable rather than stable plaque. Diagnostic imaging of vulnerable plaque is extremely useful for both stratifying patient risk and for determining effectiveness of experimental intervention in reducing cardiovascular risk. In the preclinical setting, being able to distinguish between stable and vulnerable plaque development and pair this with biochemical measures is critical for identification of new experimental candidates. In this webinar, Professor Stephen Nicholls and Dr Kristen Bubb from the Victorian Heart Institute will discuss the benefits of being able to visualise vulnerable plaque for both clinical and preclinical research. Professor Stephen Nicholls is a clinician-researcher and the Head of the Victorian Heart Institute. He is the lead investigator on multiple large, international, cardiovascular outcomes trials. He has attracted over $100 million in direct research funding and published more than 400 peer-reviewed manuscripts. He is focused on both therapeutic intervention to reduce vascular inflammation and lipid accumulation and precision medicine approaches to prevent cardiovascular mortality. Dr Kristen Bubb is a biomedical researcher and Group Leader within the Monash Biomedicine Discovery Institute Cardiovascular Program and Victorian Heart Institute. She focuses on preclinical/translational research into mechanisms underlying vascular pathologies including atherosclerosis and endothelium-driven hypertension within specific vascular systems, including pulmonary and pregnancy-induced. She has published >30 high impact papers in leading cardiovascular journals and attracted category 1&2 funding of >$750,000.
Consistency of Face Identity Processing: Basic & Translational Research
Previous work looking at individual differences in face identity processing (FIP) has found that most commonly used lab-based performance assessments are unfortunately not sufficiently sensitive on their own for measuring performance in both the upper and lower tails of the general population simultaneously. So more recently, researchers have begun incorporating multiple testing procedures into their assessments. Still, though, the growing consensus seems to be that at the individual level, there is quite a bit of variability between test scores. The overall consequence of this is that extreme scores will still occur simply by chance in large enough samples. To mitigate this issue, our recent work has developed measures of intra-individual FIP consistency to refine selection of those with superior abilities (i.e. from the upper tail). For starters, we assessed consistency of face matching and recognition in neurotypical controls, and compared them to a sample of SRs. In terms of face matching, we demonstrated psychophysically that SRs show significantly greater consistency than controls in exploiting spatial frequency information than controls. Meanwhile, we showed that SRs’ recognition of faces is highly related to memorability for identities, yet effectively unrelated among controls. So overall, at the high end of the FIP spectrum, consistency can be a useful tool for revealing both qualitative and quantitative individual differences. Finally, in conjunction with collaborators from the Rheinland-Pfalz Police, we developed a pair of bespoke work samples to get bias-free measures of intraindividual consistency in current law enforcement personnel. Officers with higher composite scores on a set of 3 challenging FIP tests tended to show higher consistency, and vice versa. Overall, this suggests that not only is consistency a reasonably good marker of superior FIP abilities, but could present important practical benefits for personnel selection in many other domains of expertise.
Seeing with technology: Exchanging the senses with sensory substitution and augmentation
What is perception? Our sensory modalities transmit information about the external world into electrochemical signals that somehow give rise to our conscious experience of our environment. Normally there is too much information to be processed in any given moment, and the mechanisms of attention focus the limited resources of the mind to some information at the expense of others. My research has advanced from first examining visual perception and attention to now examine how multisensory processing contributes to perception and cognition. There are fundamental constraints on how much information can be processed by the different senses on their own and in combination. Here I will explore information processing from the perspective of sensory substitution and augmentation, and how "seeing" with the ears and tongue can advance fundamental and translational research.
From 1D to 5D: Data-driven Discovery of Whole-brain Dynamic Connectivity in fMRI Data
The analysis of functional magnetic resonance imaging (fMRI) data can greatly benefit from flexible analytic approaches. In particular, the advent of data-driven approaches to identify whole-brain time-varying connectivity and activity has revealed a number of interesting relevant variation in the data which, when ignored, can provide misleading information. In this lecture I will provide a comparative introduction of a range of data-driven approaches to estimating time-varying connectivity. I will also present detailed examples where studies of both brain health and disorder have been advanced by approaches designed to capture and estimate time-varying information in resting fMRI data. I will review several exemplar data sets analyzed in different ways to demonstrate the complementarity as well as trade-offs of various modeling approaches to answer questions about brain function. Finally, I will review and provide examples of strategies for validating time-varying connectivity including simulations, multimodal imaging, and comparative prediction within clinical populations, among others. As part of the interactive aspect I will provide a hands-on guide to the dynamic functional network connectivity toolbox within the GIFT software, including an online didactic analytic decision tree to introduce the various concepts and decisions that need to be made when using such tools
Bedside to bench and back again, a path to translational pain research?
Pain has both a sensory and emotional component and is driven by activation of sensory neurones called nociceptors that are tuned to detect noxious stimuli in a process called nociception. Although nociception functions as a detect and protect mechanism. and is found in many organisms, this system becomes dysregulated in a number of conditions where chronic pain presents as a key symptom, for example osteoarthritis. Nociceptors do not innervate empty space though and do not act alone. Going beyond the neurone, other cell types, such as fibroblast-like synoviocytes interact with and modify the function of nociceptors, which is likely a key contributor to the chronification of pain. In this talk, I will look at how combining pre-clinical mouse work with human tissue and genetics might provide a way to accelerate new analgesics from bench to bedside, giving examples from our work in joint pain, bowel pain and labour pain.
European University for Brain and Technology Virtual Opening
The European University for Brain and Technology, NeurotechEU, is opening its doors on the 16th of December. From health & healthcare to learning & education, Neuroscience has a key role in addressing some of the most pressing challenges that we face in Europe today. Whether the challenge is the translation of fundamental research to advance the state of the art in prevention, diagnosis or treatment of brain disorders or explaining the complex interactions between the brain, individuals and their environments to design novel practices in cities, schools, hospitals, or companies, brain research is already providing solutions for society at large. There has never been a branch of study that is as inter- and multi-disciplinary as Neuroscience. From the humanities, social sciences and law to natural sciences, engineering and mathematics all traditional disciplines in modern universities have an interest in brain and behaviour as a subject matter. Neuroscience has a great promise to become an applied science, to provide brain-centred or brain-inspired solutions that could benefit the society and kindle a new economy in Europe. The European University of Brain and Technology (NeurotechEU) aims to be the backbone of this new vision by bringing together eight leading universities, 250+ partner research institutions, companies, societal stakeholders, cities, and non-governmental organizations to shape education and training for all segments of society and in all regions of Europe. We will educate students across all levels (bachelor’s, master’s, doctoral as well as life-long learners) and train the next generation multidisciplinary scientists, scholars and graduates, provide them direct access to cutting-edge infrastructure for fundamental, translational and applied research to help Europe address this unmet challenge.